United States Alzheimers Drug Market Research Report Forecast 2017-2021

March 2017 | 103 pages | ID: UF0A7161F5FEN
S&P Consulting

Abstracts

The United States Alzheimers Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Alzheimers Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Alzheimers Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Eisai
Pfizer
Decartis
Shire
Janssen
Forest Laboratories
H. Lundbeck
Merz
Daiichi Sankyo
United States Alzheimers Drug Market: Product Segment Analysis
Centrally acting AChE inhibintors
NMDA antagonists
Type 3
United States Alzheimers Drug Market: Application Segment Analysis
Application 1
Application 2
Application 3

REASONS FOR BUYING THIS REPORT

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

United States Alzheimers Drug Market Research Report Forecast 2017-2021

CHAPTER 1 ALZHEIMERS DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Alzheimers Drug
1.2 Alzheimers Drug Market Segmentation by Type
  1.2.1 United States Production Market Share of Alzheimers Drug by Type in 2015
  1.2.1 Centrally acting AChE inhibintors
  1.2.2 NMDA antagonists
  1.2.3 Type
1.3 Alzheimers Drug Market Segmentation by Application
  1.3.1 Alzheimers Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Alzheimers Drug (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON ALZHEIMERS DRUG INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES ALZHEIMERS DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 United States Alzheimers Drug Production and Share by Manufacturers (2015 and 2016)
3.2 United States Alzheimers Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Alzheimers Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Alzheimers Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Alzheimers Drug Market Competitive Situation and Trends
  3.5.1 Alzheimers Drug Market Concentration Rate
  3.5.2 Alzheimers Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES ALZHEIMERS DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Alzheimers Drug Production and Market Share by Type (2012-2017)
4.2 United States Alzheimers Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Alzheimers Drug Price by Type (2012-2017)
4.4 United States Alzheimers Drug Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES ALZHEIMERS DRUG MARKET ANALYSIS BY APPLICATION

5.1 United States Alzheimers Drug Consumption and Market Share by Application (2012-2017)
5.2 United States Alzheimers Drug Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES ALZHEIMERS DRUG MANUFACTURERS ANALYSIS

6.1 Eisai
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Pfizer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Decartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Shire
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Janssen
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Forest Laboratories
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 H. Lundbeck
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Merz
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Daiichi Sankyo
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 ALZHEIMERS DRUG MANUFACTURING COST ANALYSIS

7.1 Alzheimers Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Alzheimers Drug

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Alzheimers Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Alzheimers Drug Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES ALZHEIMERS DRUG MARKET FORECAST (2017-2021)

11.1 United States Alzheimers Drug Production, Revenue Forecast (2017-2021)
11.2 United States Alzheimers Drug Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Alzheimers Drug Production Forecast by Type (2017-2021)
11.4 United States Alzheimers Drug Consumption Forecast by Application (2017-2021)
11.5 Alzheimers Drug Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Alzheimers Drug
Table Classification of Alzheimers Drug
Figure United States Sales Market Share of Alzheimers Drug by Type in 2015
Table Application of Alzheimers Drug
Figure United States Sales Market Share of Alzheimers Drug by Application in 2015
Figure United States Alzheimers Drug Sales and Growth Rate (2011-2021)
Figure United States Alzheimers Drug Revenue and Growth Rate (2011-2021)
Table United States Alzheimers Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Alzheimers Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Alzheimers Drug Sales Share by Manufacturers
Figure 2016 Alzheimers Drug Sales Share by Manufacturers
Table United States Alzheimers Drug Revenue by Manufacturers (2015 and 2016)
Table United States Alzheimers Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Alzheimers Drug Revenue Share by Manufacturers
Table 2016 United States Alzheimers Drug Revenue Share by Manufacturers
Table United States Market Alzheimers Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Alzheimers Drug Average Price of Key Manufacturers in 2015
Figure Alzheimers Drug Market Share of Top 3 Manufacturers
Figure Alzheimers Drug Market Share of Top 5 Manufacturers
Table United States Alzheimers Drug Sales by Type (2012-2017)
Table United States Alzheimers Drug Sales Share by Type (2012-2017)
Figure United States Alzheimers Drug Sales Market Share by Type in 2015
Table United States Alzheimers Drug Revenue and Market Share by Type (2012-2017)
Table United States Alzheimers Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Alzheimers Drug by Type (2012-2017)
Table United States Alzheimers Drug Price by Type (2012-2017)
Figure United States Alzheimers Drug Sales Growth Rate by Type (2012-2017)
Table United States Alzheimers Drug Sales by Application (2012-2017)
Table United States Alzheimers Drug Sales Market Share by Application (2012-2017)
Figure United States Alzheimers Drug Sales Market Share by Application in 2015
Table United States Alzheimers Drug Sales Growth Rate by Application (2012-2017)
Figure United States Alzheimers Drug Sales Growth Rate by Application (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eisai Alzheimers Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Eisai Alzheimers Drug Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Alzheimers Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Alzheimers Drug Market Share (2012-2017)
Table Decartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Decartis Alzheimers Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Decartis Alzheimers Drug Market Share (2012-2017)
Table Shire Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Shire Alzheimers Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Shire Alzheimers Drug Market Share (2012-2017)
Table Janssen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Alzheimers Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Alzheimers Drug Market Share (2012-2017)
Table Forest Laboratories Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Forest Laboratories Alzheimers Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Forest Laboratories Alzheimers Drug Market Share (2012-2017)
Table H. Lundbeck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table H. Lundbeck Alzheimers Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table H. Lundbeck Alzheimers Drug Market Share (2012-2017)
Table Merz Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merz Alzheimers Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Merz Alzheimers Drug Market Share (2012-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Daiichi Sankyo Alzheimers Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Daiichi Sankyo Alzheimers Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimers Drug
Figure Manufacturing Process Analysis of Alzheimers Drug
Figure Alzheimers Drug Industrial Chain Analysis
Table Raw Materials Sources of Alzheimers Drug Major Manufacturers in 2015
Table Major Buyers of Alzheimers Drug
Table Distributors/Traders List
Figure United States Alzheimers Drug Production and Growth Rate Forecast (2017-2021)
Figure United States Alzheimers Drug Revenue and Growth Rate Forecast (2017-2021)
Table United States Alzheimers Drug Production Forecast by Type (2017-2021)
Table United States Alzheimers Drug Consumption Forecast by Application (2017-2021)